Author

Agnes S. M. Yong

The University of Western AustraliaORCID 0000-0001-9452-1533Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:clinical cohort / trial· 1 Approach:deep learning· 1

Frequent Co-Authors

Charles T. H. ChuahiD· 2 shared David T. O. YeungiD· 2 shared Kian Leong LeeiD· 2 shared Naranie ShanmuganathaniD· 2 shared S. Tiong OngiD· 2 shared Timothy P. HughesiD· 2 shared Vaidehi KrishnaniD· 2 shared Verity A SaundersiD· 2 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Charles T. H. ChuahORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 15, 2025

Mitochondrial DNA Mutations Determine Favourable Molecular Responses to Targeted Kinase Inhibitor Therapy and Impair Oxidative Phosphorylation

Ilaria Stefania Pagani, Vaidehi Krishnan, John F. Ouyang…·David M. Ross

This study shows that mitochondrial DNA mutations are linked to better responses to kinase inhibitor therapy and reduced oxidative phosphorylation in CML patients.

DOI 10.1101/2025.07.15.664865

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 9, 2025

Single-cell transcriptomics-guided development of flow cytometric tests predicting chronic myeloid leukemia blast crisis transformation at chronic phase diagnosis

Mengge Yu, Vaidehi Krishnan, Pavithra Shyamsundar…·S. Tiong Ong

The paper develops flow cytometry tests to predict blast crisis transformation in chronic myeloid leukemia patients using single-cell transcriptomics insights.

1 citation

humanscRNA-seq

𝕏 PostBluesky

Systems BiologybioRxivPreprintOct 10, 2024

Predicting treatment-free remission outcomes in Chronic Myeloid Leukemia patients using an integrated model of tumor-immune dynamics

Artur C. Fassoni, Agnes S. M. Yong, Richard E. Clark…·Ingmar Glauche

This paper develops a model integrating tumor-immune dynamics to predict treatment-free remission in CML patients using time-course data on NK cells and tumor load.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky